Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
BIOT
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares
NEW YORK, NY and TOKYO - September 15, 2026 (NEWMEDIAWIRE) - Instinct Bio Technical Company Holdings Inc. (Nasdaq Symbols: BIOT, BIOTW) ("Instinct Bio" or the "Company") today announced that on September 9, 2026 and September 10, 2026 it r…
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic healthcare brand “GENRÊVER…
Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
New York, NY, Las Vegas, NV, Tokyo, JP, July 23, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (“Instinct Bio,” “BIOT,” or the “Company”), the parent company of Instinct Bio Technical Company Inc, an integrated rege…
Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers
New York, NY, Las Vegas, NV, Tokyo, JP, March 24, 2026 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (OTC: ACQC) (“Relativity”), a special-purpose acquisition company, is pleased to announce that in an extraordinary general meeting held…
US Ambulatory Health Care Services Industry Report 2025: Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA
Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Ambulatory Health Care Services, Other (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA" report from Plunkett Research Ltd has been…
Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement
Las Vegas, NV, Tokyo, Japan, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Special purpose acquisition company, Relativity Acquisition Corp. (“Relativity”), and Instinct Bio Technical Company Inc. (“Instinct Bio”) today announced that on November 12,…
Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.
Las Vegas, NV, Tokyo, Japan, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (“Relativity”) today announced that on September 8, 2025, Instinct Bio Technical Company Inc. (“Instinct Bio”) publicly filed with the U.S. Securi…
Postbiotics Market Set to Surge: New Frontiers in Functional Foods and Skincare
Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to research report published by MarketsandMarkets, The globalpostbiotics market is on an impressive upward trajectory, projected to increase from USD 146.7 million in 2025 to US…
Peptide Synthesis Company Evaluation Report 2025 | Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies Lead with Advanced Instruments, Reagents, and Strategic Expansions
Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Company Evaluation Report" report has been added to ResearchAndMarkets.com's offering. The Peptide Synthesis Market Companies Quadrant is a comprehensive industry analysis th…
New York, New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) (Nasdaq: BIOT), announced today that it will not implement the extension of the time period the Company has to complete an initial business c…
The Funded: One Bay Area SPAC merger died as another headed to a vote
In more signs of trouble in the blank-check merger market, Blade Therapeutics cancelled its planned deal. Meanwhile another startup is preparing for a shareholder vote after offering a disappointing financial forecast.
The Funded: Fremont medical device maker Intuity Medical has killed its IPO plan
The company, which makes a blood glucose monitor, had planned to raise $75 million through its IPO. But a lot has changed since it filed its paperwork last fall.
Moore Kuehn Encourages BIOT, VGII, CPTK, and DSAC Investors to Contact Law Firm
NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merg…
Receiving vaccinations ‘is part of the social contract we sign up for’ in communities: Doctor
Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor, joins Yahoo Finnace Live to discuss Walmart's choice to lift mask mandates for fully vaccinated employees, COVID-19 cases declining, and Pfizer pulling FDA fi…
World Finance Named a 2022 Top Workplaces USA Winner
Award gives national recognition of company's culture, employee satisfaction GREENVILLE, SC / ACCESSWIRE / February 1, 2022 /World Finance, a people-focused finance company providing personal installment loan solutions and personal tax pre…
Investors in World Acceptance (NASDAQ:WRLD) have made a solid return of 261% over the past five years
World Acceptance Corporation (NASDAQ:WRLD) shareholders might be concerned after seeing the share price drop 13% in the last month. But that doesn't change the fact that the returns over the last five years have been very strong. Indeed, t…
MERGER ALERT – CBTX. MCFE, and BIOT: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded…
Moore Kuehn Encourages MNR, DSAC, BIOT, and ZIXI Investors to Contact Law Firm
NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
Moore Kuehn Encourages MNR, DSAC, BIOT, and ZIXI Investors to Contact Law Firm
NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed merge…
Fauci defends vaccine boosters, Moderna seeks FDA approval of booster
Anjalee Khemlani joins Brian Sozzi and Seana Smith to break down the new developments arising around COVID, including Dr. Anthony Fauci defending the administration’s decision to recommend booster shots for vaccinated people and Moderna as…
WHO urges nations to prioritize the COVAX initiative
Anjalee Khemlani joins Myles Udland and Brian Sozzi to discuss the World Health Organization’s push to prioritize the COVAX initiative that seeks to vaccinate 10% of the world’s population and its campaign to request nations to implement a…